Please login to the form below

Not currently logged in
Email:
Password:

Fanapt

This page shows the latest Fanapt news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs sleep pattern drug for blind

FDA panel backs sleep pattern drug for blind

Polymeropoulos. Vanda previously developed a schizophrenia treatment called Fanapt (iloperidone) which is licensed in North America to Novartis but has failed to make much headway in the market since its launch

Latest news

  • Vanda withdraws EU application for schizophrenia drug Vanda withdraws EU application for schizophrenia drug

    Despite the struggle for approval in the EU, the drug has been available for people with schizophrenia in the US since 2009, where it is sold under the brand name Fanapt.

  • Next generation

    Iloperidone. Fanapt (Novartis). Schizophrenia. US. Levodopa/benserazide. Co-Beneldopa (Teva Pharmaceuticals). Parkinson's disease.

  • US launch for Novartis' Fanapt

    US launch for Novartis' Fanapt. Novartis has launched schizophrenia treatment Fanapt (iloperidone) in the US, for acute treatment of schizophrenia in adults. ... In clinical trials, Fanapt was shown to be effective for the symptoms of schizophrenia.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics